(Q34535734)

2 August 2017

1 reference

title

Telomeres and telomerase in hematologic neoplasia (English)

1 reference

2 August 2017

4

Kazuma Ohyashiki

1 reference

2 August 2017

Junko H Ohyashiki

1

1 reference

2 August 2017

Goro Sashida

series ordinal

2

1 reference

2 August 2017

Tetsuzo Tauchi

series ordinal

3

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

2 August 2017

1 reference

2 August 2017

21

1 reference

2 August 2017

680-687

1 reference

2 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1205075

2 August 2017

0 references

cites work

Telomere shortening accompanies increased cell cycle activity during serial transplantation of hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

Identification of human telomerase reverse transcriptase-derived peptides that induce HLA-A24-restricted antileukemia cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

Telomere position effect in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

Excision of specific DNA-sequences from integrated retroviral vectors via site-specific recombination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

Telomerase activity in normal and malignant hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

Telomerase activity in Hodgkin's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

Expression of mutant telomerase in immortal telomerase-negative human cells results in cell cycle deregulation, nuclear and chromosomal abnormalities and rapid loss of viability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

JTB: a novel membrane protein gene at 1q21 rearranged in a jumping translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

Regulation of telomerase activity in immortal cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

Telomerase activity is induced by the stimulation to antigen receptor in human peripheral lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

Telomeric length and telomerase activity vary with age in peripheral blood cells obtained from normal individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

Specific association of human telomerase activity with immortal cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

ABL-specific tyrosine kinase inhibitor, STI571 in vitro, affects Ph-positive acute lymphoblastic leukemia and chronic myelogenous leukemia in blastic crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

Telomeres and telomerase in normal and malignant haematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

In vivo telomere dynamics of human hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

Changes in telomerase activity and telomere length during human T lymphocyte senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

Telomere length and telomerase activity in malignant lymphomas at diagnosis and relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

Accelerated telomere shortening in hematological lineages is limited to the first year following stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

Human cord blood-derived primitive progenitors are enriched in CD34+c-kit- cells: correlation between long-term culture-initiating cells and telomerase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

The use of telomerized cells for tissue engineering.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

Telomere reduction of specific chromosome translocation in acute myelocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

Formation of functional tissue from transplanted adrenocortical cells expressing telomerase reverse transcriptase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

Regulated expression of telomerase activity in human T lymphocyte development and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

Suppression of telomerase reverse transcriptase (hTERT) expression in differentiated HL-60 cells: regulatory mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

Telomeric DNA in normal and leukemic blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

Telomerase activity in chronic lymphoproliferative disorders of B-cell lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

Changes of telomere length in children after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

7 January 2021

Shortening of telomeres in recipients of both autologous and allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

7 January 2021

Genetic determinants of response to chemotherapy in transgenic mouse mammary and salivary tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

7 January 2021

Telomere length in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

7 January 2021

Telomere length in leukocyte subpopulations of patients with aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

7 January 2021

Interstitial telomere repeats in translocations of hematopoietic disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

7 January 2021

Jumping translocation at 11q23 with MLL gene rearrangement and interstitial telomeric sequences

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

7 January 2021

Telomerase activity in B-cell non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

7 January 2021

The relationship between telomere length and therapy-associated cytogenetic responses in patients with chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

7 January 2021

Telomere length changes in patients undergoing hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

7 January 2021

Telomerase activity in preleukemia and acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

7 January 2021

Accelerated telomere shortening in bone-marrow recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

7 January 2021

Transient expression of human telomerase extends the life span of normal human fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

7 January 2021

Telomerase activity and the expression of telomerase components in acute myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205075

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1205075

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference